Abstract
At least three peptides accumulating in uraemic serum inhibit glucose utilization in the rat diaphragm. The nature of these peptides is unknown. Their amino acid composition was determined. This finding is the first direct evidence differentiating the pathogenesis of abnormal glucose utilization in uraemia from that in diabetes.
Similar content being viewed by others
References
Adam, J., Dzúrik, R., Valovičová, E.: Ninhydrin-positive substances in serum and urine of patients with chronic uraemia.Clin. Chim. Acta, 37, (1972). — In Press.
Ahlers, I., Scheida, N., Körtvelyessy, S., Matejka, J., Szabó, T.: Diagnostická cena intravenózneho tolbutamidového testu u chorôb obliciek.Čas. Lék. Čes. 104, 1372 (1965).
Balestri, P. L., Biagini, M., Rindi, P., Giovanetti, S.: Uremic toxins.Arch. Int. Med. 126, 843 (1970).
Cerletty, J. M., Engbring, N. H.: Azotemia and glucose intolerance.Ann. Int. Med. 66, 1097 (1967).
Dzúrik, R., Krajči-Lazáry, B.: The effect of uremic serum on carbohydrate metabolism in rat diaphragm.Experientia, 24, 552 (1968).
Dzúrik, R., Valovičová, E.: Glucose metabolism in muscle during uremia; in vitro study.Clin. Chim. Acta 30, 137 (1970).
Dzúrik, R., Adam, J., Valovičová, E., Řezníček, J., Zvara, V.: The effect of haemodialysis on blood peptide levels.Proceedings of E.D.T.A. 8 (1971). — In Press.
Dzúrik, R., Hupková, V., Holomáň, J., Valovičová, E.: Abnormal carbohydrate metaboli in uraemia. Some properties of the inhibitor of glucose utilization present in the serum of uraemic patients.Int. Urol. Nephrol. 3, 409 (1971).
Horton, E. S., Johnson, G., Lebovitz, H. E.: Carbohydrate metabolism in uremia.Ann. Int. Med. 68, 63 (1968).
Hutchings, R. H., Hegstrom, R. M., Scribner, B. H.: Glucose intolerance in patients on long-term intermittent dialysis.Ann. Int. Med. 65, 275 (1966).
Mäsiar, P., Adam, J., Moščovič, F.: O možnostiach sledovania ninhydrín-pozitívnych látok v moči.Bratisl. lekárs. Listy 46, (I), 517 (1966).
Michl, H.: Paper electrophoresis at potential differences of 50 volts per centimeter.Monatschr. Chemie, 82, 489 (1951).
Moščovič, F., Adam, J., Mäsiar, P.: Urinary protein metabolites in acromegalic patients and normal subjects.Endocrinol. exper. 3, 131 (1969).
Perkoff, G. T., Thomas, C. L., Newton, J. D., Sellman, J. C., Tyler, F. H.: Mechanism of impaired glucose tolerance in uremia and experimental hyperazotemia.Diabetes, 7, 375 (1958).
Samaan, N. A., Freeman, R. M.: Growth hormone levels in severe renal failure.Metabolism 19, 102 (1970).
Shull, K. H., Mayer, J.: Experimental hyperglycemic states not primarily due to a lack of insulin.Vitam. Horm. 14, 187 (1956).
Westervelt, B. F. Jr., Schreiner, G. E.: The carbohydrate intolerance of uremic patients.Ann. Int. Med. 57, 266 (1962).
Wills, M. R.: Biochemical consequences of chronic renal failure. A review.J. Clin. Path. 21, 541 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dzúrik, R., Adam, J. & Grega, B. Inhibition of glucose utilization in rat diaphragm by peptides of uraemic serum isolated by high-voltage electrophoresis. International Urology and Nephrology 4, 297–301 (1972). https://doi.org/10.1007/BF02081883
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02081883